{"address1": "No.8, Nanke 7th Road", "address2": "Shanhua District", "city": "Tainan City", "zip": "741", "country": "Taiwan", "phone": "886 8 0080 0980", "website": "https://www.genmont.com.tw", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "GenMont Biotech Incorporation engages in the research, development, production, and sale of functional probiotic products in Taiwan. The company also offers probiotics with special functions; and original formula design and manufacturing, and equipment manufacturing services on health care food, as well as cooperates in the research, production, and clinical trial of various products. GenMont Biotech Incorporation was founded in 2000 and is headquartered in Tainan City, Taiwan.", "maxAge": 86400, "priceHint": 2, "previousClose": 25.15, "open": 25.1, "dayLow": 24.4, "dayHigh": 25.1, "regularMarketPreviousClose": 25.15, "regularMarketOpen": 25.1, "regularMarketDayLow": 24.4, "regularMarketDayHigh": 25.1, "dividendRate": 1.1, "dividendYield": 0.0437, "exDividendDate": 1656028800, "payoutRatio": 1.6667, "beta": 0.33825, "trailingPE": 37.045456, "volume": 73786, "regularMarketVolume": 73786, "averageVolume": 115496, "averageVolume10days": 144072, "averageDailyVolume10Day": 144072, "bid": 24.4, "ask": 24.6, "bidSize": 0, "askSize": 0, "marketCap": 2111771008, "fiftyTwoWeekLow": 21.0, "fiftyTwoWeekHigh": 31.05, "priceToSalesTrailing12Months": 5.7300067, "fiftyDayAverage": 24.246, "twoHundredDayAverage": 24.25775, "trailingAnnualDividendRate": 0.7, "trailingAnnualDividendYield": 0.027833002, "currency": "TWD", "enterpriseValue": 1951725696, "profitMargins": 0.1546, "sharesOutstanding": 86371000, "heldPercentInsiders": 0.37093, "heldPercentInstitutions": 0.00426, "impliedSharesOutstanding": 0, "bookValue": 15.646, "priceToBook": 1.5626998, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1672444800, "earningsQuarterlyGrowth": -0.687, "netIncomeToCommon": 56978000, "trailingEps": 0.66, "lastSplitFactor": "110:100", "lastSplitDate": 1276560000, "enterpriseToRevenue": 5.296, "enterpriseToEbitda": 17.757, "52WeekChange": -0.07195574, "SandP52WeekChange": -0.033239067, "lastDividendValue": 1.1, "lastDividendDate": 1656028800, "exchange": "TAI", "quoteType": "EQUITY", "symbol": "3164.TW", "underlyingSymbol": "3164.TW", "shortName": "GENMONT BIOTECH INC", "longName": "GenMont Biotech Incorporation", "firstTradeDateEpochUtc": 1221786000, "timeZoneFullName": "Asia/Taipei", "timeZoneShortName": "CST", "uuid": "9576e760-1106-38ab-be2b-75904e62001b", "messageBoardId": "finmb_20343535", "gmtOffSetMilliseconds": 28800000, "currentPrice": 24.45, "recommendationKey": "none", "totalCash": 400943008, "totalCashPerShare": 4.642, "ebitda": 109915000, "totalDebt": 34545000, "quickRatio": 2.816, "currentRatio": 3.244, "totalRevenue": 368545984, "debtToEquity": 2.307, "revenuePerShare": 4.267, "returnOnAssets": 0.022820001, "returnOnEquity": 0.03141, "grossProfits": 256717000, "freeCashflow": 78653376, "operatingCashflow": 137948000, "earningsGrowth": -0.686, "revenueGrowth": -0.111, "grossMargins": 0.69657, "ebitdaMargins": 0.29824, "operatingMargins": 0.16815001, "financialCurrency": "TWD", "trailingPegRatio": null}